Filter Releases
 
Press Releases
Date Title and Summary View
Oct 28, 2014
WALTHAM, Mass., Oct. 28, 2014 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS) announced today that its Vice President, Business Development & Strategy, Geoffrey A. Swire, will present at the BIO-Europe Conference on Wednesday, November 5, 2014 at 12:45 p.m. Central European Time at the Portalhaus Messe Frankfurt, in Frankfurt, Germany. BI...
Oct 23, 2014
WALTHAM, Mass., Oct. 23, 2014 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS) announced today it is a sponsor of The Cancer Support Community's symposium, "The Patient Voice: The First Year of the Cancer Experience Registry," in recognition of National Breast Cancer Awareness Month. Radius is pleased to help be a sponsor of this patient-focus...
Oct 21, 2014
WALTHAM, Mass., Oct. 21, 2014 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq:RDUS) announced today that it will release its third quarter 2014 financial results on Tuesday, November 11, 2014. In connection with the earnings release, Radius Health will host a conference call and live audio webcast at 8:00 a.m. ET on Tuesday, November 11, 2014 to disc...
Oct 2, 2014
WALTHAM, Mass., Oct. 2, 2014 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS), a science-driven biopharmaceutical company focused on developing new therapeutics for patients with advanced osteoporosis as well as other serious endocrine-mediated diseases, including hormone responsive cancers, announced today that it has priced its public offeri...
Oct 1, 2014
WALTHAM, Mass., Oct. 1, 2014 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS), a science-driven biopharmaceutical company focused on developing new therapeutics for patients with advanced osteoporosis as well as other serious endocrine-mediated diseases, including hormone responsive cancers, today announced that it is commencing an underwritte...
Sep 25, 2014
Radius Health Summarizes Recent Presentations regarding its Investigational Drug Abaloparatide at the American Society for Bone and Mineral Research and for its Investigational Drug RAD1901 at the 4th Annual Brain Metastases Research and Emerging Therapy ConferenceInvestigational Drug Abaloparatide Currently in Phase 3 Clinical Development, Top Lin...
Sep 11, 2014
CAMBRIDGE, Mass., Sept. 11, 2014 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS) announced today that its President and CEO, Robert Ward, will present at the BioCentury NewsMakers in the Biotech Industry Conference on Friday, September 26, 2014 at 2:00 p.m. Eastern Time at the Millennium Broadway Hotel & Conference Center in New York. ...
Sep 8, 2014
Live Panel And Conference Call Scheduled for 7:30 a.m. CDT on September 15, 2014 Data Presented During Poster Session at ASBMR 2014 WALTHAM, Mass., Sept. 8, 2014 (GLOBE NEWSWIRE) -- Radius Health, Inc. ("Radius") (Nasdaq:RDUS), a science-driven biopharmaceutical company focused on developing new therapeutics for patients with oste...
Aug 28, 2014
WALTHAM, Mass., Aug. 28, 2014 (GLOBE NEWSWIRE) -- Radius Health, Inc. ("Radius") (Nasdaq:RDUS), a science-driven biopharmaceutical company focused on developing novel differentiated therapeutics for patients with osteoporosis as well as other serious endocrine-mediated diseases, reports that the positron emission tomography (PET) imaging from the R...
Aug 19, 2014
CAMBRIDGE, Mass., Aug. 19, 2014 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS) announced today that it will present new data from multiple studies of abaloparatide in women with postmenopausal osteoporosis at the American Society for Bone and Mineral Research (ASBMR) 2014 Annual Meeting, which takes place September 12-15, 2014 in Houston, Te...
Aug 12, 2014
WALTHAM, Mass., Aug. 12, 2014 (GLOBE NEWSWIRE) -- Radius Health, Inc. ("Radius") (Nasdaq:RDUS), a science-driven biopharmaceutical company focused on developing novel differentiated therapeutics for patients with osteoporosis as well as other serious endocrine-mediated diseases, reported its financial results for the second quarter ended June 30, 2...
Aug 7, 2014
CAMBRIDGE, Mass., Aug. 7, 2014 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq:RDUS) announced today that its President and CEO, Robert Ward, will present at the Canaccord Genuity 34th Annual Growth Conference on Wednesday, August 13, 2014 at 10:30 a.m. Eastern Time at the Intercontinental Hotel in Boston. The presentation will be webcast live on the...
Aug 6, 2014
CAMBRIDGE, Mass., Aug. 6, 2014 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq:RDUS) announced today that it will release its second quarter 2014 financial results on Tuesday, August 12, 2014. In connection with the earnings release, Radius Health will host a conference call and live audio webcast at 8.30 a.m. ET on Tuesday, August 12, 2014 to discus...
Jun 18, 2014
CAMBRIDGE, Mass., June 18, 2014 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq:RDUS), will present scientific data from studies conducted with abaloparatide (BA058) at the joint meeting of the International Society of Endocrinology and the Endocrine Society (ICE/ENDO 2014) in Chicago, Illinois, June 21-24, 2014. Abstracts related to Radius Health in...
Jun 5, 2014
CAMBRIDGE, Mass., June 5, 2014 (GLOBE NEWSWIRE) -- Radius Health, Inc. ("Radius") announced today that it has priced its initial public offering of 6,500,000 shares of its common stock at a public offering price of $8.00 per share. In addition, Radius has granted the underwriters a 30-day option to purchase up to an additional 975,000 shares of com...
= add release to Briefcase